While tax incentives are well-suited to incentivising more R&D across all industries and types of firms, at low administrative cost, direct support is often better suited to providing targeted incentives for R&D and innovation in critical fields that policymakers consider might be experiencing underinvestment. In many countries such fields have included new markets (such as personalised medicine, or autonomous vehicles), societal challenges (such as the aging population, and low-carbon growth), and transitions such as in advanced manufacturing and digitalisation. Accordingly, a balanced policy mix is needed that takes full advantage of the relative strengths of both direct and tax-based public support instruments for business R&D. Most OECD countries operate such a mix. This institution, for instance the BMVIT, should take the initiative and develop a monitoring system as described above.